Clinical trial
A Phase I Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
NCT02133625 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- January 31, 2026
- Enrollment
- 14 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumor, metastatic solid tumor